However, restricting the authorisation of this novel food and of the reference to the 90-day oral toxicity study, to the assessment study of the antihypertensive effects and safety of the refined shrimp peptide concentrate in healthy humans with mild or moderate hypertension, and to the double-blind, placebo-controlled, parallel study on the assessment of anti-hypertensive effect and safety of a the refined shrimp peptide concentrate dietary supplement in healthy humans with mild or moderate hypertension, contained in the Applicant's file for the sole use of the Applicant does not prevent other applicants from applying for an authorisation to place on the market the same novel food provided that their application is based on legally obtained information supporting the authorisation under this Regulation.
Aangezien het maatregelen van algemene strekking betreft tot wijziging van niet-essentiële onderdelen van deze richtlijn, onder meer door haar aan te vullen met nieuwe niet-essentiële onderdelen, moeten zij worden vastgesteld volgens de in artikel # bis van Besluit #/#/EG bepaalde regelgevingsprocedure met toetsingEurlex2018q4 Eurlex2018q4